Analyst Research

Report Title Price
Provider: GlobalData
$250.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Pharming Group NV's Sanofi Chimie Receives Approval to Manufacture Drug Substance for Ruconest


Thursday, 28 Mar 2013 02:00am EDT 

Pharming Group NV announced that it has received approval from the European Medicines Agency (EMA) for Sanofi Chimie to manufacture drug substance for Pharming's product Ruconest at their Aramon (France) site. Sanofi Chimie is acting as Pharming's Contract Manufacturing Organization. The Contract Manufacturing process requires a complex purification process. Three different chromatography steps are necessary to obtain a drug substance. 

Related Company News

Company Quote

0.585
-0.03 -4.88%
11 Feb 2014